POAS (Phaos Technology Holdings Cayman) EBITDA: $-3.38 Mil (TTM As of Oct. 2025)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

POAS Phaos Technology Holdings Cayman Ltd POAS
4 GF Score
Price $0.22
! 5 Warning Signs
View Full Analysis

What is Phaos Technology Holdings Cayman EBITDA?

Phaos Technology Holdings Cayman POAS -6.08% 4 EBITDA is $-3.38 Mil as of Oct. 2025. GuruFocus rates POAS with a GF Score™ of 4/100. The stock has 5 warning signs investors should review.

Phaos Technology Holdings Cayman's EBITDA for the six months ended in Oct. 2025 was $-1.09 Mil. Its EBITDA for the trailing twelve months (TTM) ended in Oct. 2025 was $-3.38 Mil.

Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the EBITDA Growth Rate using EBITDA data.

Phaos Technology Holdings Cayman's EBITDA per Share for the six months ended in Oct. 2025 was $-0.08. Its EBITDA per share for the trailing twelve months (TTM) ended in Oct. 2025 was $-0.25.

Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the EBITDA per share growth rate using EBITDA per Share data.

Phaos Technology Holdings Cayman  (AMEX:POAS) EBITDA Explanation

EBITDA is a cash flow measure that ignores changes in working capital. EBITDA minus Depreciation, and Amortization (DA) equals Operating Income. Operating Income is profit before interest and taxes. Of course, Interest and taxes need to be paid.

While depreciation and amortization expenses do not need to be paid in cash, assets - especially tangible assets - do need to be replaced over time. EBITDA is not a measure of profit in any sense. EBITDA is a measure of cash generation by a business where the uses of that cash may be more or less discretionary depending on the nature of the business.

The EBITDA of a TV station is largely discretionary. Owners may use much of the EBITDA generated by a TV station as they see fit. The EBITDA of a railroad is largely non-discretionary. Owners must use much of the EBITDA generated by a railroad to replace the physical assets of the railroad or the business will literally fall apart over time.

EBITDA can be thought of as the cash a business generates that is available to:

Add more inventory
Add more receivables
Replace property, plant, and equipment
Add more property, plant, and equipment
Pay interest
Pay taxes
And finally: pay owners

EBITDA is widely used in financial analysis because Depreciation and Amortization are not present day cash expenses.. Depreciation and amortization are the spreading out of the costs of assets over the time in which those assets provide benefits. Today's depreciation and amortization expenses relate to assets bought in the past. The assets being expensed may or may not need to be replaced in the future. And the cost to replace the assets may be more or less than it was in the past. For this reason, the depreciation and amortization expenses a company records in the present year may have no relationship to the actual cash costs needed to maintain its assets in future years.

A company's depreciation expense depends on both its expectations about the assets it owns and its choice of accounting methods. Two companies owning identical assets may have different depreciation expenses because they have different expectations about the useful lives of those assets and because they make different accounting choices.

Analysts use EBITDA to remove this element of personal choice from a company's accounting statements. The use of EBITDA is an attempt to make the results of different companies more comparable and uniform.


Be Aware

Although depreciation is not a cash cost it is a real business cost because the company has to pay for the fixed assets when they purchase them. Both Warren Buffett and Charlie Munger hate the idea of EBITDA because in this calculation, depreciation is not counted as an expense.

EBITDA over Revenue is a good metric for comparing the operating efficiencies between companies because EBITDA is less vulnerable to companies' accounting choices. For this reason, EBITDA is used in ranking the Predictability of Companies. Also Price-to-EBITDA is sometimes used in valuations.


Phaos Technology Holdings Cayman EBITDA Related Terms


Phaos Technology Holdings Cayman EBITDA Historical Data

* Premium members only.

The historical data trend for Phaos Technology Holdings Cayman's EBITDA can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Phaos Technology Holdings Cayman EBITDA Chart

Phaos Technology Holdings Cayman Annual Data
Trend Apr23 Apr24 Apr25
EBITDA
-1.09 -1.58 -3.74

Phaos Technology Holdings Cayman Semi-Annual Data
Apr23 Oct23 Apr24 Oct24 Apr25 Oct25
EBITDA Get a 7-Day Free Trial -1.03 -0.54 -1.46 -2.29 -1.09

POAS vs WOK, ITOC, INBS: EBITDA Comparison

For the Medical Devices subindustry, Phaos Technology Holdings Cayman's EV-to-EBITDA, along with its competitors' market caps and EV-to-EBITDA data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Phaos Technology Holdings Cayman EV-to-EBITDA vs Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Phaos Technology Holdings Cayman's EV-to-EBITDA distribution charts can be found below:

* The bar in red indicates where Phaos Technology Holdings Cayman's EV-to-EBITDA falls into.


POAS
4GF Score
Phaos Technology Holdings Cayman Ltd POAS
EBITDA is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Earnings Before Interest, Taxes, Depreciation, and Amortization (EBITDA) is what the company earns before it expenses interest, taxes, depreciation and amortization.

Phaos Technology Holdings Cayman's EBITDA for the fiscal year that ended in Apr. 2025 is calculated as

Phaos Technology Holdings Cayman's EBITDA was directly provided by GuruFocus' data source Morningstar. For the fiscal year ended in Apr. 2025, Phaos Technology Holdings Cayman's EBITDA was $-3.74 Mil.

Phaos Technology Holdings Cayman's EBITDA for the quarter that ended in Oct. 2025 is calculated as

Phaos Technology Holdings Cayman's EBITDA was directly provided by GuruFocus' data source Morningstar. For the quarter ended in Oct. 2025, Phaos Technology Holdings Cayman's EBITDA was $-1.09 Mil.

EBITDA for the trailing twelve months (TTM) ended in Oct. 2025 adds up the semi-annually data reported by the company within the most recent 12 months, which was $-3.38 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Sometimes companies may have already deducted Depreciation and Amortization from Gross Profit. In this case Depreciation and Amortization needs to be added back when calculating EBITDA.

Frequently Asked Questions Learn more about EBITDA →
What does a EBITDA of $-3.38 Mil mean?
Phaos Technology Holdings Cayman (POAS) has a EBITDA of $-3.38 Mil as of Oct. 2025. Ebitda is the difference between operating revenue and operating expenses not including depreciation and amortization. View historical data on Phaos Technology Holdings Cayman.
Is Phaos Technology Holdings Cayman's EBITDA too high?
Phaos Technology Holdings Cayman's current EBITDA is $-3.38 Mil. Overall, Phaos Technology Holdings Cayman has a GF Score™ of 4/100, reflecting its overall financial health beyond just this single metric.
How does Phaos Technology Holdings Cayman's EBITDA compare to WOK and ITOC?
Phaos Technology Holdings Cayman's EBITDA of $-3.38 Mil can be compared against companies in the Medical Devices & Instruments industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EBITDA for a Medical Devices & Instruments company?
A good EBITDA depends on the Medical Devices & Instruments industry context. However, EBITDA should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EBITDA mean?
A high EBITDA can signal that a stock is expensive relative to its fundamentals. Ebitda is the difference between operating revenue and operating expenses not including depreciation and amortization. View historical data on Phaos Technology Holdings Cayman. Phaos Technology Holdings Cayman's current EBITDA is $-3.38 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Phaos Technology Holdings Cayman stock overvalued right now?
Phaos Technology Holdings Cayman (POAS) has a current EBITDA of $-3.38 Mil. The current EBITDA is $-3.38 Mil. Phaos Technology Holdings Cayman's overall GF Score™ is 4/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EBITDA calculated?
EBITDA is calculated from a company's financial statements. For Phaos Technology Holdings Cayman (POAS), the current EBITDA is $-3.38 Mil as of Oct. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Phaos Technology Holdings Cayman Business Description

Address 83 Science Park Drive, 02-01 & 04-01A/B The Curie, Singapore Science Park 1, Singapore, SGP, 118258
Phaos Technology Holdings Cayman Ltd is an investment holding company incorporated in the Cayman Islands. Through its subsidiaries, the Company engages in the research, development, manufacturing, and commercialization of advanced optical technologies and products. Leveraging its patented microsphere technology, Phaos enhances the magnification of traditional optical microscopes, enabling visualization beyond the 200nm optical limit at a commercially viable working distance. The Company offers advanced microscopy equipment and parts, along with AI-powered software solutions that complement its hardware to deliver fully integrated microscopy systems. Its technologies serve diverse sectors, including manufacturing, biomedical, and research.
4GF Score

Get the complete analysis for POAS

EBITDA is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$0.22
Price